Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Price:
108.58 USD
-1.73%
Market Closed
Updated:
May 17, 2024
Jazz Pharmaceuticals PLC
Interest Income Expense
|
Jazz Pharmaceuticals PLC
Interest Income Expense Peer Comparison
Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Interest Income Expense
-$277.6m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-24%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Interest Income Expense
-$175.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Interest Income Expense
-$9.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Interest Income Expense
$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Interest Income Expense
-€4.5m
|
CAGR 3-Years
31%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Interest Income Expense
-€47k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jazz Pharmaceuticals PLC's Interest Income Expense?
Interest Income Expense
-277.6m
USD
-277.6m
USD
Based on the financial report for Mar 31, 2024, Jazz Pharmaceuticals PLC's Interest Income Expense amounts to -277.6m USD.
What is Jazz Pharmaceuticals PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-24%
-24%
Over the last year, the Interest Income Expense growth was 7%. The average annual Interest Income Expense growth rates for Jazz Pharmaceuticals PLC have been -38% over the past three years , -28% over the past five years , and -24% over the past ten years .
You don't have any saved screeners yet
